McKesson Corporation
MCKMcKesson Corporation (MCK) is a Healthcare company that currently yields 0.32% — historically overvalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $208.70 and the overvaluation threshold at $690.73. McKesson Corporation holds a quality score of 40/100 (Average), reflecting 14 consecutive years of dividend growth with a 8% payout ratio. The 5-year dividend CAGR stands at -5.0%.
MCK Dividend Yield History — Weiss Valuation
Distance to undervalued
Entry price is stretched
Needs 72.8% downside to reach the Weiss buy zone
Undervaluation starts near $208.70, where the annual dividend would imply roughly 1.19% yield. That is 0.86% above today's yield.
Buy-zone price
$208.70
Target yield
1.19%
Research checklist
What to clear before buying the yield
Updated May 25, 2026
Dividend durability
14YLong dividend history supports a deeper look.
Earnings payout
8%Earnings coverage leaves room for noise.
Cash payout
7%Free cash flow coverage supports the payment.
Dividend growth
-5.0%Lower growth changes the return trade-off.
What changed
What changed since the last update
2026-05-23 → 2026-05-25
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
McKesson Corporation is trading near its historical overvaluation band.
Current yield 0.3% vs historical max 1.2% (28% of maximum).
Recent dividend history shows no sustained growth streak.
Conservative payout ratio of 8%.
What matters now
Read the signal before the headline yield
Valuation is the brake here: the yield is compressed versus its own history.
The 40/100 quality score says the headline yield needs extra skepticism.
Start by checking whether payout coverage and business durability still support the dividend.
MCK Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$32
Year 10 Income
$33
Yield on Cost
0.33%
Total Income
$328
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗MCK Dividend Quality Score
Quality Score
Average
Key Metrics
Invest in MCK
Buy McKesson Corporation commission-free on eToro
Start investing on eToro →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ MCK Dividend Analysis Article